Swiss National Bank Reduces Stake in IDEXX Laboratories

Institutional investor sells 13,400 shares of the diagnostic products and services company.

Published on Mar. 10, 2026

Got story updates? Submit your updates here. ›

Swiss National Bank, an institutional investor, reduced its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 5.5% during the 3rd quarter, according to a recent 13F filing with the SEC. The bank now owns 231,900 shares of the company's stock, worth approximately $148,159,000.

Why it matters

IDEXX Laboratories is a leading global provider of diagnostic products and services for the animal health, water testing, and food safety markets. The reduction in Swiss National Bank's stake could signal a shift in investor sentiment or portfolio rebalancing, which may impact the stock price and market perception of the company.

The details

According to the 13F filing, Swiss National Bank sold 13,400 shares of IDEXX Laboratories during the 3rd quarter, reducing its total stake to 231,900 shares. The bank now owns approximately 0.29% of the company's outstanding shares. IDEXX Laboratories is a well-known and respected player in the animal health and diagnostics industry, with a strong market position and growth potential.

  • The 13F filing was submitted in the 3rd quarter of the year.

The players

Swiss National Bank

A major institutional investor and central bank of Switzerland.

IDEXX Laboratories, Inc.

A global developer, manufacturer, and provider of diagnostic products and services primarily for the animal health, water testing, and food safety markets.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Swiss National Bank's stake in IDEXX Laboratories could be a sign of broader market shifts or portfolio rebalancing, but it does not necessarily indicate any significant concerns about the company's fundamentals or future prospects. IDEXX Laboratories remains a leading player in the animal health and diagnostics industry.